Clinical Trials in Denver

Showing 1181-1200 of 15,604 trials

A Study to Investigate Safety and Effectiveness of CRN09682 in Participants With SST2-Expressing NENs and Other Solid Tumors

NCT07129252

This Phase 1/2, multicenter, open-label, FIH study aims to evaluate the safety, tolerability, PK, and preliminary antitumor activity of CRN09682 in participants with SST2-expressing NENs and other solid tumors. The study includes a Dose Escalation Phase to determine the MTD and DLTs. Following MTD identification, additional participants will be enrolled at the expansion dose to further assess safety, tolerability, PK, and antitumor activity.

SST2-positive Neuroendocrine NeoplasmsNeuroendocrine TumorsNeuroendocrine Neoplasm

Crinetics Pharmaceuticals Inc.150 participantsStarted Nov 2025

Duarte, California, United States • Newport Beach, California, United States • Orange, California, United States +18 more locations

Active Not RecruitingPhase 38.4 miles

A Study to Investigate the Efficacy and Safety of Volrustomig ± Casdatifan vs Nivolumab + Ipilimumab as 1L Treatment for Advanced ccRCC

NCT07000149

This is a Phase Ib/III, randomized, multicenter, global study evaluating the efficacy and safety of volrustomig in combination with casdatifan for the first-line (1L) treatment of participants with advanced clear cell renal cell carcinoma (ccRCC).

Advanced Clear Cell Renal Cell Carcinoma

AstraZeneca1,116 participantsStarted Jul 2025

La Jolla, California, United States • Aurora, Colorado, United States • Boston, Massachusetts, United States +29 more locations

A Study to Investigate Safety and Effectiveness of CRN09682 in Participants With SST2-Expressing NENs and Other Solid Tumors

A Study to Investigate the Efficacy and Safety of Volrustomig ± Casdatifan vs Nivolumab + Ipilimumab as 1L Treatment for Advanced ccRCC

Find Trials by Condition in Denver

Phase 1-2 Study of Low Dose ASTX727 (ASTX727 LD) in Lower Risk MDS

Pembrolizumab (MK-3475) Versus Placebo Following Surgery and Radiation in Participants With Locally Advanced Cutaneous Squamous Cell Carcinoma (MK-3475-630/KEYNOTE-630)

Open Label, Long-term Study Evaluating Safety and Efficacy of Subcutaneous Amlitelimab in Participants Aged 12 Years and Older With Moderate to Severe Atopic Dermatitis

A Study of Lasmiditan (LY573144) Treatment in Children Aged 6 to 17 With Migraine

Streamlined Treatment of Pulmonary Exacerbations in Pediatrics

Type 1 Diabetes Extension Study

OsteoGen Plug vs. Freeze-dried Bone Allograft With Collagen Barrier

Study of GalaFLEX LITE™ Scaffold in Treatment of Capsular Contracture After Breast Implant Augmentation

Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRAGMATYK)

Study to Evaluate the Safety, Tolerability, PDs, and Efficacy of CNP-104 in Subjects With Primary Biliary Cholangitis

A Global Prospective Observational Registry of Patients With Pompe Disease

Dose Optimization and Expansion Study of DFV890 in Adult Patients With Myeloid Diseases

Antibiotic Cement Bead Pouch Versus Negative Pressure Wound Therapy

A 12-Month Study of Lasmiditan (LY573144) Treatment in Children Aged 6 to 17 With Migraine

Advancing Cath Lab Results With FFRangio Coronary Physiology Assessment

Efficacy and Safety of Tildrakizumab Compared to Placebo in Anti-TNF naïve Subjects With Active Psoriatic Arthritis II (INSPIRE 2)

Long-term Safety and Efficacy Evaluation of Lunsekimig in Adult Participants With Chronic Rhinosinusitis With Nasal Polyps (CRSwNP) Who Completed a Previous Lunsekimig CRSwNP Study

STRatIfication of Vulvar SCC by HPV and p53 Status to Guide Excision